NDC 51688-9780 - A1573-17 CONTINUOUS EPIDURAL 17G HUSTEAD
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51688-9780
- Package NDCs from labels
- 51688-9780-2
- Manufacturer
- Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.
- Effective date
- 2012-11-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Povidone-Iodine - Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 2012-11-16 | MEDICAL DEVICE |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hemorrhoid | LIDOCAINE HCL, PHENYLEPHRINE HCL, WITCH HAZEL | Walgreens Co | 10a47899-f4a0-66e8-e063-6394a90a11dd | 2024-02-05 | Warnings | EC2CNF7XFP |
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Sterile Water | STERILE WATER | Chartwell RX, LLC | 3681eeaa-807a-47ca-9fbc-61c2b682800a | 2024-02-01 | 059QF0KO0R | |
| Sterile Water | WATER | A-S Medication Solutions | dba87371-31d2-47c2-ab83-89aabce4b184 | 2024-01-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Natrum Muriaticum | SODIUM CHLORIDE | SEVENE USA | 11008014-fff6-4d5a-8c5c-a20443d7cc23 | 2024-01-30 | Warnings | 451W47IQ8X |
| BUPIVACAINE HCI AND EPINEPHRINE | BUPIVACAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 99516811-56e2-9c8a-e053-2a95a90ac9cb | 2024-01-30 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 946ce625-3647-5083-e053-2a95a90a1ebc | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | c0d1def8-9f47-0d3e-e053-2995a90af955 | 2024-01-30 | Warnings, Adverse reactions | YKH834O4BH |
| XYLOCAINE | XYLOCAINE | HF Acquisition Co LLC, DBA HealthFirst | e3b3b462-8f35-68b8-e053-2995a90a6403 | 2024-01-27 | Warnings, Adverse reactions | EC2CNF7XFP |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a14ca7d9-de30-a303-e053-2a95a90a5304 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | e5247ed5-6170-c13f-e053-2a95a90a4101 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| XYLOCAINE- MPF (LIDOCAINE HCl ) | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e8b987c8-b5cb-74cd-e053-2a95a90a5a93 | 2024-01-27 | Warnings, Adverse reactions | EC2CNF7XFP |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 451W47IQ8X |
| CIRCULATION HP | ARNICA MONTANA, AURUM METALLICUM, CACTUS GRANDIFLORUS, CALCAREA CARBONICA, LACHESIS MUTUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, SOLIDAGO VIRGAUREA, | Energique, Inc. | 464d208b-3893-4ec6-9868-12ef6807b98d | 2024-01-23 | Warnings | 451W47IQ8X |
| DERMA SCALE HP | ARSENICUM IODATUM, BORAX, GRAPHITES, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PETROLEUM, SEPIA, SULPHUR | Energique, Inc. | 64961787-7e9a-4e6f-98ce-0f51934155cf | 2024-01-23 | Warnings | 451W47IQ8X |
| XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 971439ed-4507-7a30-e053-2a95a90a1f1c | 2024-01-22 | Warnings, Adverse reactions | EC2CNF7XFP |
| LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 94e9f2db-af29-032e-e053-2995a90a7f7b | 2024-01-22 | Warnings, Adverse reactions | EC2CNF7XFP |
| BUPIVACAINE HCI | BUPIVACAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | e37e1599-db88-2fcd-e053-2995a90a00e5 | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | f9c82678-5f4d-fded-e053-6394a90ac16d | 2024-01-22 | Warnings, Adverse reactions | YKH834O4BH |
| BUPIVACAINE HYDROCHLORIDE injection, solution | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION | HF Acquisition Co LLC, DBA HealthFirst | 06c15208-c600-7173-e063-6394a90a2f94 | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.